Merck & Co. - North Wales, PA
posted 2 months ago
Access to our medicines is a strategic pillar for our organization and the Oncology Organized Customer Access and Reimbursement (OCAR) team is positioned to support that endeavor. Our goal is to provide profitable product access across our Oncology portfolio, and we engage with customers across the payer, provider, channel and policy spectrums to develop solutions that support patient access to our medicines. As a part of our Oncology OCAR (Organized Customer Marketing Access and Reimbursement) team, the Director, New Product Payer Marketing, will provide oversight in the development of access strategies for our New Products portfolio. The Director will be responsible for managing the early access planning for 10+ new oncology assets in our pipeline, providing support for projects supporting list price, lifecycle gross to net and discount/contracting assumptions, IRA legislation and policy impacts, site of care and dispense assumptions, and payer, provider and pathway value message planning. Early asset development decisions can have major impacts to future access strategies and go to market executions. The Director will collaborate with multiple stakeholders within our organization, including our Global Access Teams, Global Marketing Teams, US New Product and In-line Marketing Teams, IRA teams, Finance and our Research & Development Division value evidence teams to ensure transparency and alignment to future access opportunities and challenges. Working closely with our stakeholders this role will be responsible for providing oversight, leadership and management that will include but not limited to the following: Management and developmental support of the Associate Director for New Products, who will be focused on the assets closer to launch and transitioning those products to our OCAR in-line team for launch. Oversight to the creation and maintenance of an early access strategies for each portfolio asset including: Input on evidence generation and evidence needs value messaging list price strategy contracting options across segments, inclusive of value-based approaches distribution customer segment / site of care strategy payer policy inclusion provider access and reimbursement patient access and OOP pathway inclusion impact of legislative policy Support of portfolio-based access strategies Finance alignment and management of access inputs to annual and long-term forecasting for new products Pre-approval information exchange strategy (PIE) Capability building creation and maintenance of modeling, research, dashboards and analysis supporting early product access. Oversight of transition planning to in-line team for products closer to launch.